-
1
Pediatric psoriasis is a chronic inflammatory disease with distinct clinical and systemic implications compared to adult-onset psoriasis.
-
2
It is associated with comorbidities such as obesity, psychological disorders, and inflammatory conditions like psoriatic arthritis.
-
3
Management of pediatric psoriasis is complicated by access barriers, age restrictions, off-label use, and limited long-term safety data.
-
4
Major unmet needs include delayed drug development, insufficient evaluation of extracutaneous outcomes, and lack of updated therapeutic algorithms.
-
5
Future advances will require pediatric-focused research and integrated multidisciplinary strategies to improve long-term outcomes.
